Priyabatra Mukherjee
#171,450
Most Influential Person Now
Chemistry researcher
Priyabatra Mukherjee's AcademicInfluence.com Rankings
Priyabatra Mukherjeechemistry Degrees
Chemistry
#5504
World Rank
#6696
Historical Rank
Organic Chemistry
#989
World Rank
#1117
Historical Rank
Download Badge
Chemistry
Priyabatra Mukherjee's Degrees
- PhD Chemistry University of California, Berkeley
- Masters Chemistry University of California, Berkeley
- Bachelors Chemistry University of Calcutta
Why Is Priyabatra Mukherjee Influential?
(Suggest an Edit or Addition)According to Wikipedia, Priyabrata Mukherjee is an American, academic researcher and professor. He is a Presbyterian Health Foundation presidential professor at the University of Oklahoma Health Sciences Center and associate director for translational research at Stephenson Cancer Center at the OU Health Sciences Center. He also holds the Peggy and Charles Stephenson endowed chair in cancer laboratory research at the OU Health Sciences Center.
Priyabatra Mukherjee's Published Works
Number of citations in a given year to any of this author's works
Total number of citations to an author for the works they published in a given year. This highlights publication of the most important work(s) by the author
Published Works
- The use of microorganisms for the formation of metal nanoparticles and their application (2005) (914)
- Human hepatic stellate cell lines, LX-1 and LX-2: new tools for analysis of hepatic fibrosis (2004) (836)
- Biological properties of "naked" metal nanoparticles. (2008) (785)
- Effect of nanoparticle surface charge at the plasma membrane and beyond. (2010) (524)
- Intrinsic therapeutic applications of noble metal nanoparticles: past, present and future. (2012) (509)
- Antiangiogenic Properties of Gold Nanoparticles (2005) (414)
- Gold nanoparticles: opportunities and challenges in nanomedicine (2010) (404)
- Fabrication of gold nanoparticles for targeted therapy in pancreatic cancer. (2010) (388)
- Targeted delivery of gemcitabine to pancreatic adenocarcinoma using cetuximab as a targeting agent. (2008) (321)
- Inorganic Nanoparticles in Cancer Therapy (2011) (316)
- Modulating Pharmacokinetics, Tumor Uptake and Biodistribution by Engineered Nanoparticles (2011) (312)
- Intracellular gold nanoparticles enhance non-invasive radiofrequency thermal destruction of human gastrointestinal cancer cells (2008) (266)
- MiR-15a and MiR-16 control Bmi-1 expression in ovarian cancer. (2009) (243)
- Potential therapeutic application of gold nanoparticles in B-chronic lymphocytic leukemia (BCLL): enhancing apoptosis (2007) (201)
- Cystathionine Beta-Synthase (CBS) Contributes to Advanced Ovarian Cancer Progression and Drug Resistance (2013) (199)
- Attaching folic acid on gold nanoparticles using noncovalent interaction via different polyethylene glycol backbones and targeting of cancer cells (2007) (185)
- Mechanism of anti-angiogenic property of gold nanoparticles: role of nanoparticle size and surface charge. (2011) (181)
- Inhibition of tumor growth and metastasis by a self-therapeutic nanoparticle (2013) (173)
- Inhibition of Vascular Permeability Factor/Vascular Endothelial Growth Factor-mediated Angiogenesis by the Kruppel-like Factor KLF2* (2005) (160)
- Gold Nanoparticles Inhibit VEGF165-Induced Proliferation of HUVEC Cells (2004) (138)
- On the issue of transparency and reproducibility in nanomedicine (2019) (128)
- Role of Hedgehog Signaling in Ovarian Cancer (2008) (127)
- Gold Nanoparticle Reprograms Pancreatic Tumor Microenvironment and Inhibits Tumor Growth. (2016) (115)
- MICU1 drives glycolysis and chemoresistance in ovarian cancer (2017) (103)
- Hydrogen sulfide signaling in mitochondria and disease (2019) (103)
- Cystathionine β‐synthase regulates endothelial function via protein S‐sulfhydration (2016) (98)
- Noninvasive radiofrequency field-induced hyperthermic cytotoxicity in human cancer cells using cetuximab-targeted gold nanoparticles. (2008) (98)
- Identifying New Therapeutic Targets via Modulation of Protein Corona Formation by Engineered Nanoparticles (2012) (91)
- In vivo toxicity studies of europium hydroxide nanorods in mice. (2009) (89)
- Fabrication and functional characterization of goldnanoconjugates for potential application in ovarian cancer. (2010) (84)
- Regulatory role of dynamin‐2 in VEGFR‐2/KDR‐mediated endothelial signaling (2005) (83)
- Enhancing Chemotherapy Response with Bmi-1 Silencing in Ovarian Cancer (2011) (83)
- Nanoconjugation modulates the trafficking and mechanism of antibody induced receptor endocytosis (2010) (73)
- Understanding Protein–Nanoparticle Interaction: A New Gateway to Disease Therapeutics (2014) (72)
- Sensitization of ovarian cancer cells to cisplatin by gold nanoparticles (2014) (63)
- Therapeutic evaluation of microRNA-15a and microRNA-16 in ovarian cancer (2016) (63)
- Inhibition of BMI1 induces autophagy-mediated necroptosis (2016) (59)
- Hybrid Nanosystems for Biomedical Applications. (2021) (58)
- Designing Nanoconjugates to Effectively Target Pancreatic Cancer Cells In Vitro and In Vivo (2011) (57)
- Inorganic phosphate nanorods are a novel fluorescent label in cell biology (2006) (56)
- Src homology 2 (SH2) domain containing protein tyrosine phosphatase-1 (SHP-1) dephosphorylates VEGF Receptor-2 and attenuates endothelial DNA synthesis, but not migration* (2008) (54)
- LPA Induces Metabolic Reprogramming in Ovarian Cancer via a Pseudohypoxic Response. (2018) (52)
- Fabrication and characterization of an inorganic gold and silica nanoparticle mediated drug delivery system for nitric oxide (2010) (50)
- Nanoparticle Interactions with the Tumor Microenvironment. (2019) (47)
- Intracellular fate of a targeted delivery system (2008) (47)
- Gold Nanoparticles Bearing Functional Anti-Cancer Drug and Anti-Angiogenic Agent: A "2 in 1" System with Potential Application in Cancer Therapeutics (2005) (45)
- Sonochemically prepared BSA microspheres containing Gemcitabine, and their potential application in renal cancer therapeutics. (2009) (44)
- Efficient Delivery of Gold Nanoparticles by Dual Receptor Targeting (2011) (44)
- Switching the targeting pathways of a therapeutic antibody by nanodesign. (2012) (43)
- Lanthanide phosphate nanorods as inorganic fluorescent labels in cell biology research. (2007) (41)
- Tuning Pharmacokinetics and Biodistribution of a Targeted Drug Delivery System Through Incorporation of a Passive Targeting Component (2014) (39)
- Probing Novel Roles of the Mitochondrial Uniporter in Ovarian Cancer Cells Using Nanoparticles*♦ (2013) (39)
- Cancer nanotechnology: emerging role of gold nanoconjugates. (2011) (36)
- Evaluating the Mechanism and Therapeutic Potential of PTC-028, a Novel Inhibitor of BMI-1 Function in Ovarian Cancer (2017) (35)
- Role of cystathionine beta synthase in lipid metabolism in ovarian cancer (2015) (34)
- Gold Nanoparticles sensitize pancreatic cancer cells to gemcitabine (2019) (33)
- Protein-mediated autoreduction of gold salts to gold nanoparticles (2008) (32)
- Gold nanoparticle transforms activated cancer-associated fibroblasts to quiescence. (2019) (30)
- Cystathionine β‐synthase regulates mitochondrial morphogenesis in ovarian cancer (2018) (29)
- Inhibiting the Growth of Pancreatic Adenocarcinoma In Vitro and In Vivo through Targeted Treatment with Designer Gold Nanotherapeutics (2013) (29)
- Gold Nanoparticles Disrupt Tumor Microenvironment - Endothelial Cell Cross Talk To Inhibit Angiogenic Phenotypes in Vitro. (2019) (28)
- Strategies for Delivering Nanoparticles across Tumor Blood Vessels (2020) (27)
- Analysing the nanoparticle-protein corona for potential molecular target identification. (2020) (27)
- Labeling of Sperm Cells via the Spontaneous Penetration of Eu3+ Ions as Nanoparticles Complexed with PVA or PVP (2008) (27)
- MDR1 mediated chemoresistance: BMI1 and TIP60 in action. (2016) (25)
- When the chains do not break: the role of USP10 in physiology and pathology (2020) (24)
- Gold nanoparticles inhibit activation of cancer-associated fibroblasts by disrupting communication from tumor and microenvironmental cells (2020) (21)
- Switching the intracellular pathway and enhancing the therapeutic efficacy of small interfering RNA by auroliposome (2020) (21)
- Gold Nanoparticles do not Affect the Global Transcriptional Program of Human Umbilical Vein Endothelial Cells: A DNA-Microarray Analysis (2005) (20)
- MicroRNA‐195 controls MICU1 expression and tumor growth in ovarian cancer (2020) (19)
- Mitochondrial BMI1 maintains bioenergetic homeostasis in cells (2016) (18)
- Synergistic Interventional Photothermal Therapy and Immunotherapy Using an Iron Oxide Nanoplatform for the Treatment of Pancreatic Cancer. (2021) (18)
- Hepatoma derived growth factor (HDGF) dynamics in ovarian cancer cells (2016) (18)
- Fabrication of gold nanoparticle for potential application in multiple myeloma (2008) (18)
- Cystathionine beta synthase regulates mitochondrial dynamics and function in endothelial cells (2020) (17)
- Experimental conditions influence the formation and composition of the corona around gold nanoparticles (2021) (15)
- Small Non-Coding-RNA in Gynecological Malignancies (2021) (14)
- BMI1, a new target of CK2α (2017) (14)
- Aberrant expression of JNK-associated leucine-zipper protein, JLP, promotes accelerated growth of ovarian cancer (2016) (13)
- Sepsis in the era of data-driven medicine: personalizing risks, diagnoses, treatments and prognoses (2019) (13)
- Revealing macropinocytosis using nanoparticles. (2021) (13)
- Targeting Pancreatic Cancer Cells and Stellate Cells Using Designer Nanotherapeutics in vitro (2020) (13)
- Inhibition of BMI1, a Therapeutic Approach in Endometrial Cancer (2018) (12)
- A simple synthesis of a targeted drug delivery system with enhanced cytotoxicity. (2011) (12)
- Active Targeting Significantly Outperforms Nanoparticle Size in Facilitating Tumor-Specific Uptake in Orthotopic Pancreatic Cancer. (2021) (12)
- A core-shell nanomaterial with endogenous therapeutic and diagnostic functions (2010) (12)
- Cystathione β-synthase regulates HIF-1α stability through persulfidation of PHD2 (2020) (11)
- Nanogold in Cancer Therapy and Diagnosis (2007) (10)
- Cystathionine β-Synthase Is Necessary for Axis Development in Vivo (2018) (9)
- Patient-Derived Xenografts of High-Grade Serous Ovarian Cancer Subtype as a Powerful Tool in Pre-Clinical Research (2021) (8)
- Vascular Endothelial Growth Factor as an Immediate-Early Activator of Ultraviolet-Induced Skin Injury. (2021) (7)
- Targeting the TGFβ pathway in uterine carcinosarcoma (2020) (6)
- Correction: potential therapeutic application of gold nanoparticles in B-chronic lymphocytic leukemia (BCLL): enhancing apoptosis (2013) (6)
- Targeted delivery using inorganic nanosystem. Preface. (2010) (6)
- Probing Cellular Processes Using Engineered Nanoparticles. (2018) (6)
- KRCC1: A potential therapeutic target in ovarian cancer (2019) (5)
- Unraveling Autocrine Signaling Pathways through Metabolic Fingerprinting in Serous Ovarian Cancer Cells (2021) (5)
- Ubiquitin‐binding associated protein 2 regulates KRAS activation and macropinocytosis in pancreatic cancer (2020) (5)
- Improved pentamethine cyanine nanosensors for optoacoustic imaging of pancreatic cancer (2021) (4)
- Gold Nanoparticles Disrupt the IGFBP2/mTOR/PTEN Axis to Inhibit Ovarian Cancer Growth (2022) (4)
- Evaluation of I-TAC as a potential early plasma marker to differentiate between critical and non-critical COVID-19 (2021) (3)
- Publisher Correction: On the issue of transparency and reproducibility in nanomedicine (2019) (3)
- Controlling Nanoparticle Uptake in Innate Immune Cells with Heparosan Polysaccharides. (2022) (2)
- Synthesis of Silver Nanocubes by Photoreduction of Silver Salts in the Presence of Proteins (2011) (2)
- Disabling partners in crime: Gold nanoparticles disrupt multicellular communications within the tumor microenvironment to inhibit ovarian tumor aggressiveness. (2022) (2)
- Nano-ablative immunotherapy for cancer treatment (2021) (2)
- Hepatoma‐Derived Growth Factor (HDGF) Acts in Ovarian Cancer via Distinct Intracellular and Extracellular Mechanisms (2015) (1)
- Gold nanoparticles and airway hyperreactivity (2011) (1)
- Wireless Graphene-Based Quantum Capacitance Sensors for Continuous Glucose Monitoring (2013) (1)
- Publisher Correction: On the issue of transparency and reproducibility in nanomedicine (2019) (1)
- Corrigendum: Cystathionine β-Synthase Is Necessary for Axis Development in vivo (2018) (1)
- Self-Therapeutic Nanomaterials: Applications in Biology and Medicine. (2022) (1)
- NCCTG N0338: effect of docetaxel and carboplatin on VEGF, PGE2, and immune cells in patients with stage II or III breast cancer. (2009) (0)
- Role Of Surface Charge In Gold Nanoparticle Interactions With The Human Airway (2011) (0)
- Gold Nanoparticles Inhibit Macropinocytosis by Decreasing KRAS Activation. (2023) (0)
- Correction (2013) (0)
- Vascular Endothelial Growth Factor as an Immediate-Early Activator of UV-induced Skin Injury (2020) (0)
- Nanoparticles Uniporter in Ovarian Cancer Cells Using Probing Novel Roles of the Mitochondrial Signal Transduction (2013) (0)
- Abstract 1882: Role of cystathionine beta-synthase in ovarian cancer growth, metastasis and drug sensitivity. (2013) (0)
- The deubiquitinase USP10 protects pancreatic cancer cells from endoplasmic reticulum stress (2022) (0)
- Depletion of BMI1 Induces Autophagy Mediated Necroptosis (2016) (0)
- Hepatoma derived growth factor (HDGF) dynamics in ovarian cancer cells (2015) (0)
- μ Opioid Receptor Stimulates a Growth Promoting and Pro-Angiogenic Tumor Microenvironment by Transactivating VEGF Receptor-2/Flk-1. (2005) (0)
- BMI1, a new target of CK2α (2017) (0)
- Rücktitelbild: Switching the Targeting Pathways of a Therapeutic Antibody by Nanodesign (Angew. Chem. 7/2012) (2012) (0)
- Back Cover: Switching the Targeting Pathways of a Therapeutic Antibody by Nanodesign (Angew. Chem. Int. Ed. 7/2012) (2012) (0)
- Protein can act as unique template to assemble gold nanoparticles in a linear fashion. (2006) (0)
- Role Of Nanoparticle Surface Charge In Modulating Airway Inflammation (2012) (0)
- KRCC1, a modulator of the DNA damage response (2022) (0)
- Hydrochemical Evaluation of Water Quality and Trophic State Status of Saheb Bandh Lake, Purulia (2017) (0)
- Abstract B062: Activation of the MAPK pathway by altered RNA splicing in cancer (2022) (0)
- Targeting BMI1 mitigates chemoresistance in ovarian cancer (2022) (0)
- Activation of ERK by altered RNA splicing in cancer (2022) (0)
This paper list is powered by the following services:
Other Resources About Priyabatra Mukherjee
What Schools Are Affiliated With Priyabatra Mukherjee?
Priyabatra Mukherjee is affiliated with the following schools:
